Speaker Profile

BIOGRAPHY

Sarah Adam coordinates IFPMA’s regulatory activities, focusing on policy, system strengthening, and harmonization across global and regional levels (LATAM, Asia, Africa). She leads workstreams on Biotherapeutics and Advanced Therapies internationally. A Board-Certified Medical Affairs Specialist, Sarah holds a Ph.D. in Molecular Biology and an Engineering degree in Biotechnology. She has over 10 years of research experience in vaccines and pulmonary disease drug development and previously supported ICH guideline harmonization. Sarah also served as a lecturer at the University of Geneva’s School of Pharmacy.